ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2016 American Transplant Congress

    Proteoforms: Novel Biomarkers for Acute Rejection in Liver Transplant Recipients.

    J. Levitsky,1 T. Toby,1 K. Kim,1 I. Ntai,1 A. Demetris,2 M. Abecassis,1 P. Thomas,1 N. Kelleher.1

    1Northwestern, Chicago; 2UPMC, Pittsburgh.

    Background: Biomarker profiles diagnostic of acute rejection (AR) in liver transplant (LT) recipients could enhance the diagnosis and management of recipients. Our aim was to…
  • 2016 American Transplant Congress

    Effect of Complement Inhibition Therapy (Eculizumab) in Patients with C1q-Binding Donor-Specific Anti-HLA Antibodies: A Molecular Appraisal.

    C. Lefaucheur,1 L. Hidalgo,2 J. Reeve,2 D. Viglietti,1 C. Gosset,1 O. Aubert,3 C. Ulloa,3 C. Legendre,3 D. Glotz,1 P. Halloran,2 A. Loupy.3

    1Saint-Louis Hospital, Paris, France; 2University of Alberta, Edmonton, Canada; 3Necker Hospital, Paris, France.

    Complement-binding anti-HLA DSA have demonstrated higher rejection rate and decreased allograft outcome. We investigated the effect of terminal complement inhibition (Eculizumab) in a cohort of…
  • 2016 American Transplant Congress

    Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10.

    J. Ho,1 A. Sharma,2 R. Mandal,3 D. Wishart,3 C. Wiebe,1 L. Storsley,1 M. Karpinski,1 I. Gibson,4 P. Nickerson,1 D. Rush.1

    1Internal Medicine, University of Manitoba, Winnipeg, MB, Canada; 2Pediatrics & Child Health, University of Manitoba, Winnipeg, MB, Canada; 3Biological Sciences, University of Alberta, Edmonton, AB, Canada; 4Pathology, University of Manitoba, Winnipeg, MB, Canada.

    Background. We studied urine metabolomics (UM) alone or combined with urine CXCL10 to non-invasively detect cellular infiltrates in renal allograft biopsies.Methods. Urines (n=137) were obtained…
  • 2016 American Transplant Congress

    Bortezomib Impacts Tenascin mRNA in PBMNCs.

    E. Bradley, O. Moussa, K. Twombley.

    Medical University of South Carolina, Charleston.

    Tenascin (TNC) is a gene thought to play a role in the binding of receptors and syndecan binding. Syndecans are signal transmembrane proteins that act…
  • 2016 American Transplant Congress

    Clinical Impact of Pre-Transplant Serum 25-Hydroxyvitamin D Levels on the Post-Transplant Immunologic and Non-Immunologic Outcomes in Kidney Transplant Recipients.

    T. Ban,1,2 J. Kim,1,2 Y. Lee,1 B. Choi,1,2 C. Park,1,2 C. Yang,1,2 Y.-S. Kim,1,2 B. Chung.1,2

    1Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, Korea; 2Transplant Research Center, Seoul St. Mary's Hospital, Seoul, Korea.

    Background: The aim of this study is to investigate the clinical significance of pre-transplant serum 25-hydroxyvitamin D (25(OH)D) levels in regard to post-transplant clinical outcome…
  • 2016 American Transplant Congress

    Impact of Preformed Anti-HLA Antibodies in the Outcomes of Kidney Transplantation.

    S. Santos,1 J. Malheiro,1 M. Costa,2 A. Campos,1 S. Pedroso,1 M. Almeida,1 L. Martins,1 L. Dias,1 C. Henriques,1 A. Cabrita.1

    1Nephrology, Hospital Santo António, CHP, Porto, Portugal; 2Nephrology, Centro Hospitalar Tondela-Viseu, Viseu, Portugal.

    Background:Anti-HLA antibodies are risk factors for acute and chronic rejection and allograft loss. Its detection represents a major advance and is widely used in organ…
  • 2016 American Transplant Congress

    Anti-HLA Antibody Composition and Outcomes in Pediatric Heart Transplant Recipients with a Positive Cross-Match.

    P. Jindra,1 S. Nicholas,2 J. Chappelle,1 T. Humlicek,2 K. Hosek,2 J. Heinle,2 S. Denfield,2 A. Jeewa,2 R. Kerman,1 W. Dreyer.2

    1Surgery Immune Evaluation Lab, Baylor College of Medicine, Houston, TX; 2Pediatrics, Baylor College of Medicine, Houston, TX.

    Purpose: Utilization of positive (+) cross-match (XM) hearts is tempting when shortages of pediatric donor hearts exist, especially for patients with high pre-transplant panel reactive…
  • 2016 American Transplant Congress

    Risk of Acute Rejection Among ABO Incompatible Living Donor Kidney Recipients.

    P. MacLennan, V. Kumar, R. Reed, D. Mompoint-Williams, K. Stegner, J. Locke.

    School of Medicine, University of Alabama at Birmingham, Birmingham, AL.

    Background: ABO incompatible (ABOi) live donor kidney transplantation (LDKT) holds the potential for increased access to transplantation for ESRD patients. Concerns remain related to the…
  • 2016 American Transplant Congress

    Antithymocyte (ATG) Dose Density in Renal Transplant Recipients (RTR) with Early Graft Dysfunction (EGD).

    S. Kuten, S. Patel, R. Knight, D. Nguyen, E. Graviss, H. Podder, A. Gaber.

    Houston Methodist Hospital, Houston, TX.

    The cumulative amount of ATG for induction may be given as consecutive (cDD) or intermittent day dosages (iDD). iDD allows for leukocyte or platelet recovery…
  • 2016 American Transplant Congress

    Diffuse Extent of Peritubular Capillaritis in Late Antibody Mediated Rejection Is Associated with More Severe Chronic Allograft Damage.

    Z. Kikić,1 F. Eskandary,1 H. Herkner,2 R. Oberbauer,1 G. Bond,1 H. Regele,3 G. Böhmig,1 N. Kozakowski.3

    1Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria; 2Emergency Medicine, Medical University of Vienna, Vienna, Austria; 3Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria.

    Peritubular capillaritis (ptc) is a widely accepted histologic criterion of antibody-mediated rejection (ABMR), and while the ptc score is incorporated in current diagnostic recommendations, the…
  • « Previous Page
  • 1
  • …
  • 148
  • 149
  • 150
  • 151
  • 152
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences